Manufacturing decline yields drug shortages

Science

Volumn 333, Issue 6039, 2011, Pages 156-157

  Connelly, Patrick ^a   Quinn, Brian Patrick ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; GENERIC DRUG;

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; GOVERNMENT REGULATION; HUMAN; LETTER; LEUKEMIA; PRIORITY JOURNAL; PROFIT; PUBLIC HEALTH; UNITED STATES;

ANTINEOPLASTIC AGENTS; CYTARABINE; DRUG INDUSTRY; PRIVATE SECTOR; PUBLIC SECTOR; UNITED STATES;

EID: 79960082870     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.333.6039.156-b     Document Type: Letter

References (4)

1. A. Grove, "How America can create jobs," Bloomberg Businessweek, published online 1 July 2010 (www.businessweek.com/magazine/ content/10-28/b4186048358596.htm).
2. A. N. Liveris, Make It in America: The Case for Re-Inventing the Economy (Wiley, Hoboken, NJ, 2011).
3. M. E. Porter, M. R. Kramer, Harv. Business Rev. 89, 62 (2011).
4. P. R. Connelly, B. P. Quinn, P. Hurter, J. Condon, P. Mueller, Pharm. Outsourcing 11, 16 (2010).